During the last session, Bio-Key International Inc (NASDAQ:BKYI)’s traded shares were 0.3 million, with the beta value of the company hitting 0.25. At the end of the trading day, the stock’s price was $1.24, reflecting an intraday loss of -6.06% or -$0.08. The 52-week high for the BKYI share is $4.43, that puts it down -257.26 from that peak though still a striking 58.06% gain since the share price plummeted to a 52-week low of $0.52. The company’s market capitalization is $3.85M, and the average intraday trading volume over the past 10 days was 12.44 million shares, and the average trade volume was 4.83 million shares over the past three months.
Bio-Key International Inc (NASDAQ:BKYI) trade information
Bio-Key International Inc (BKYI) registered a -6.06% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -6.06% in intraday trading to $1.24, hitting a weekly high. The stock’s 5-day price performance is 78.52%, and it has moved by 74.65% in 30 days. Based on these gigs, the overall price performance for the year is -64.56%. The short interest in Bio-Key International Inc (NASDAQ:BKYI) is 12813.0 shares and it means that shorts have 0.04 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Bio-Key International Inc (BKYI) estimates and forecasts
Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 91.90% this quarter and then jump 68.10% in the quarter after that.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 1.6M as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 1.9M by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 32.10%. While earnings are projected to return 80.52% in 2024.
BKYI Dividends
Bio-Key International Inc is due to release its next quarterly earnings on 2024-Nov-18. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Bio-Key International Inc (NASDAQ:BKYI)’s Major holders
Bio-Key International Inc insiders own 5.41% of total outstanding shares while institutional holders control 5.42%, with the float percentage being 5.73%.
